PTC Therapeutics Inc. buy UBS Group AG
Start price
26.08.24
/
50%
€31.00
Target price
26.08.25
€42.11
Performance (%)
34.19%
End price
27.08.25
€41.60
Summary
This prediction ended on 27.08.25 with a price of €41.60. With a performance of 34.19% the BUY prediction by UBS_Group_AG was a big success. UBS_Group_AG has a follow-up prediction for PTC Therapeutics Inc. where he still thinks PTC Therapeutics Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| PTC Therapeutics Inc. | -5.000% | -5.000% | 73.830% |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % |
Comments by UBS_Group_AG for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $47.00 price target on the stock.
Ratings data for PTCT provided by MarketBeat
In the thread Trading PTC Therapeutics Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€43.60
29.07.25
29.07.25
€68.98
29.07.26
29.07.26
51.79%
28.07.26
28.07.26
Stopped prediction by UBS_Group_AG for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.60
03.12.24
03.12.24
€67.48
03.12.25
03.12.25
28.02%
04.12.25
04.12.25